Reimbursed Care Access in North Korea

Currently classified as a strictly controlled substance under international drug control instruments (1971 UN Convention on Psychotropic Substances) and, under DPRK domestic narcotics control law, there is no authorised medical access for psychoactive hallucinogens outside approved research or tightly controlled medical practice. Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. MDMA is listed under international psychotropic controls (1971 Convention) and DPRK implements strict domestic controls and criminal penalties for illicit manufacture, trafficking and possession under its Narcotic Drugs Control framework. # #

Esketamine (a prescription nasal formulation marketed in some countries for treatment‑resistant depression) is not known to be approved or marketed in the DPRK healthcare system. There are no public records of regulatory approval, reimbursement pathways, or national-level mental‑health licensing for esketamine in DPRK; any administration would likely be limited to experimental or research contexts under state medical authorities. Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. (No DPRK regulatory approval or reimbursement documentation located in public international sources.) # #

Ketamine is internationally recognized as an essential anaesthetic and is listed on the World Health Organization Model List of Essential Medicines, which supports its legitimate medical use worldwide. #

Under international drug‑control practice the WHO/INCB framework distinguishes ketamine from many classic psychedelics because ketamine is an accepted medicine for anaesthesia and pain management; DPRK has engaged with UN drug‑control bodies on implementation of international conventions and has domestic narcotics law that permits use of narcotic/psychotropic substances for medical purposes when prescribed by state authorities. The International Narcotics Control Board reported a mission to the DPRK in 2019 that discussed implementation of the international drug control conventions with the DPRK Ministry of Public Health, indicating engagement on licit medical supplies and controls. # #

Practical implications for patients: in DPRK the health system is state‑run and medical licensing and procurement are centrally controlled; ketamine is therefore likely available within state hospitals for anaesthesia and emergency care under ministry protocols rather than via commercial reimbursement schemes. There is no public evidence of private‑insurance style reimbursement, nor of outpatient psychiatric use or approved ketamine‑based depression programs in DPRK. Reimbursement status (i.e., whether the state health system covers ketamine costs for individual patients) is not documented in publicly available sources; given DPRK’s centrally planned health system, licit medical use would be determined and supplied via Ministry of Public Health channels rather than by private insurers. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. N,N‑Dimethyltryptamine (DMT) is controlled internationally under the 1971 UN Convention and DPRK’s domestic narcotics framework enforces strict controls on internationally scheduled psychotropics. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. 5‑MeO‑DMT is treated as a controlled tryptamine in many jurisdictions and falls within the scope of international psychotropic controls; DPRK’s drug legislation and practice apply strict prohibitions and criminal penalties for illicit handling of such substances. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Ibogaine is not uniformly scheduled by the UN conventions (national approaches vary), but in practice DPRK’s narcotics legislation and strict enforcement practices mean there is no authorised therapeutic ibogaine access for the public; clinical use would, at most, be confined to exceptional research permitted by state authorities. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. While plant materials themselves occupy a complex legal position internationally, DPRK’s domestic narcotics law and strict controls provide no recognised exemption for traditional plant medicines containing scheduled tryptamines (e.g., DMT) — hence no authorised public access. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mescaline is internationally controlled; DPRK law enforces prohibitions on internationally scheduled hallucinogens and applies criminal penalties for unauthorised possession, manufacture or trafficking. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. The 2C‑series phenethylamines are psychotropic substances often controlled under national law as part of lists of synthetic hallucinogens; DPRK’s narcotics legislation and enforcement make illicit manufacture, distribution and possession punishable offences. # #